UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy Journal article
Zhu, Lipeng, Li, Junnan, Guo, Ziang, Kwok, Hang Fai, Zhao, Qi. Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy[J]. Journal of Nanobiotechnology, 2022, 20(1), 521.
Authors:  Zhu, Lipeng;  Li, Junnan;  Guo, Ziang;  Kwok, Hang Fai;  Zhao, Qi
Favorite | TC[WOS]:10 TC[Scopus]:13  IF:10.6/11.4 | Submit date:2023/01/30
Anti-pd-l1 Nanobody  Hypoxia Modulation  Immune-cold Tumors  Immunogenic Cell Death  Nano-nuclear-reactor  t Cell Immune Activation